Funding Details
- Awarder
- Inbox
- Date Award
- March 17, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$80,300,000
Company Info
- Founding Year
- 2014
- Founders
- Flagship Pioneering, Daniel Anderson, Ph.D., Robert Langer, Sc.D.
- Company Description
- Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.
- Market
- Chronic diseases
- Location
-
Cambridge,
MA,
USA
- Coinvestors
- BlackRock, Canada Pension Plan Investment Board, Eli Lilly and Company, Flagship Pioneering, Longevity Vision Fund
Links